Social and environmental risk factors in the emergence of infectious diseases

Nature Medicine

Volumn 10, Issue 12S, 2004, Pages S70-S76

  Weiss, Robin A ^a   McMichael, Anthony J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BEHAVIOR; BIOLOGICAL WARFARE; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CANCER; CARDIOVASCULAR DISEASE; CHOLERA; CIGARETTE SMOKING; CLIMATE CHANGE; CREUTZFELDT JAKOB DISEASE; DIARRHEA; DISEASE TRANSMISSION; EBOLA VIRUS; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI O157; FOOD CONTAMINATION; FOREST; HEPATITIS C; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IATROGENIC DISEASE; INFECTION RISK; INJURY; LASSA FEVER; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; MALARIA; MEDICAL TECHNOLOGY; MIGRATION; NIPAH VIRUS; NONHUMAN; ORGAN TRANSPLANTATION; POLITICS; POVERTY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RURAL AREA; SEVERE ACUTE RESPIRATORY SYNDROME; SOCIAL PROBLEM; SOCIOECONOMICS; STAPHYLOCOCCUS AUREUS; TUBERCULOSIS; URBAN AREA; URBANIZATION; VACCINE PRODUCTION; VIBRIO CHOLERAE; VIRUS HEMORRHAGIC FEVER; VIRUS INFECTION; VIRUS TRANSMISSION; WAR; WORLD HEALTH ORGANIZATION;

CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; COMMUNICABLE DISEASES, EMERGING; DEMOGRAPHY; DISEASE OUTBREAKS; HEALTH; HUMANS; INTERNATIONAL COOPERATION; NEOPLASMS; PUBLIC HEALTH; RISK; RISK FACTORS; TIME FACTORS; WORLD HEALTH;

AVES; BOVINAE; EBOLA VIRUS; ESCHERICHIA COLI; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LEGIONELLA; LEGIONELLA PNEUMOPHILA; NIPAH VIRUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; VIBRIO; VIBRIO CHOLERAE;

EID: 10944220947     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1150     Document Type: Review

References (60)

1. Burnet, F.M. & White, D. Natural History of Infectious Disease (Cambridge Univ. Press, Cambridge, 1972).
2. McMichael, A.J. Human Frontiers, Environments and Disease. Past patterns, uncertain futures (Cambridge Univ. Press, Cambridge, 2001).
3. Morens, D.M., Folkers, G.K. & Fauci, A.S. The challenge of emerging and re-emerging infectious diseases. Nature 430, 242-249 (2004).
4. McMichael, A.J. Environmental and social influences on emerging infectious diseases: Past, present and future. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359, 1049-1058 (2004).
5. McMichael, A.J., McKee, M., Shkolnikov, V. & Valkonen, T. Mortality trends and setbacks: Global convergence or divergence? Lancet 363, 1155-1159 (2004).
6. Garrett, L. Betrayal of Trust: The Collapse of Global Public Health (Hyperion, New York, 2000).
7. Johnson, N.P. & Mueller, J. Updating the accounts: Global mortality of the 1918-1920 “Spanish” influenza pandemic. Bull. Hist. Med. 76, 105-115 (2002).
8. Webby, R., Hoffmann, E. & Webster, R. Molecular constraints to interspecies transmission of viral pathogens. Nat. Med. 10, S77-S81 (2004).
9. Palese, P. Influenza: Old and new threats. Nat. Med. 10, S82-S87 (2004).
10. De Clercq, E. Antivirals and antiviral strategies. Nat. Rev. Microbiol. 2, 704-720 (2004).
11. Taylor, L.H., Latham, S.M. & Woolhouse, M.E. Risk factors for human disease emergence. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 983-939 (2001).
12. Weiss, R.A. Virulence and pathogenesis. Trends Microbiol. 10, 314-317 (2002).
13. Speck, R.S. Cholera. in The Cambridge World History of Human Disease (ed. Kiple, K.F.) 642-647 (Cambridge Univ. Press, Cambridge, 1993).
14. Raoult, D. et al. Jail fever (epidemic typhus) outbreak in Burundi. Emerg. Infect. Dis. 3, 357-360 (1997).
15. McNeill, W.H. Plagues and Peoples (Penguin, London, 1976).
16. Drancourt, M. et al. Genotyping, orientalis-like Yersinia pestis, and plague pandemics. Emerg. Infect. Dis. 10, 1585-1592 (2004).
17. Diamond, J. Guns, Germs and Steel. A Short History of Everybody for the Last 13, 000 Years (Jonathan Cape, London, 1997).
18. Duffy, J. Smallpox and the Indians in the American colonies. Bull. Hist. Med. 25, 324-341 (1951).
19. Anderson, R.M. & May, R.M. Infectious Diseases of Humans: Dynamics and Control (Oxford Univ. Press, 1992).
20. Patz, J.A. et al. Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence. Environ. Health. Perspect. 112, 1092-1098 (2004).
21. Chua, K.B. et al. Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet354, 1257-1259 (1999).
22. Halpin, K., Young, P.L., Field, H. & Mackenzie, J.S. Newly discovered viruses of flying foxes. Vet. Microbiol. 68, 83-87 (1999).
23. Parmenter, R., Brunt, J., Moore, D. & Ernest, S. The hantavirus epidemic in the southwest: Rodent population dynamics and the implications for transmission of hantavirus-associated adult respiratory distress syndrome (HARDS) in the four corners region. Sevilleta LTER Publ. (University of New Mexico) 41, 1-44 (1993).
24. Engelthaler, D.M. et al. Climatic and environmental patterns associated with hantavirus pulmonary syndrome, Four Corners region, United States. Emerg. Infect. Dis. 5, 87-94 (1999).
25. MacKenzie, J.S., Gubler, D.J. & Petersen, L.R. Emerging flaviviruses: The spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10, S98-S109 (2004).
26. Frenzen, F.D. Deaths due to unknown foodborne agents. Emerg. Infect. Dis. 10, 1536-1543 (2004).
27. Will, R.G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925 (1996).
28. Schwartz, M. How the Cows Turned Mad (University of California Press, London, 2003).
29. Wilson, K. & Ricketts, M.N. Transfusion transmission of vCJD: A crisis avoided? Lancet364, 477-479 (2004).
30. Koopmans, M. et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363, 587-593 (2004).
31. Lee, K. & KewalRamani, V.N. In defense of the cell: TRIM5a interception of mammalian retroviruses. Proc. Natl. Acad. Sci. USA 101, 10496-10497 (2004).
32. Hahn, B.H., Shaw, G.M., De Cock, K.M. & Sharp, P.M. AIDS as a zoonosis: Scientific and public health implications. Science287, 607-614 (2000).
33. Brockmann, D. Dynamics of epidemics spread across airline networks. in SARS: A Case Study in Emerging Infections (eds. McLean, A.R., May, R., Pattison, J.R. & Weiss, R.A.) (Oxford Univ. Press, Oxford, 2005).
34. Caldwell, J.C. Rethinking the African AIDS epidemic. Popul. Dev. Rev. 26, 117-135 (2000).
35. Butler, C. HIV and AIDS, poverty, and causation. Lancet356, 1445-1446 (2000).
36. Auvert, B. et al. Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection. AIDS 15 Suppl 4, S15-S30 (2001).
37. Johnson, A.M. et al. Sexual behaviour in Britain: Partnerships, practices, and HIV risk behaviours. Lancet358, 1835-1842 (2001).
38. Morse, S.S. Factors in the emergence of infectious diseases. Emerg. Infect. Dis. 1, 7-15 (1995).
39. Cohen, A. Urban unfinished business. Int. J. Environ. Health Res. 13, S29-S36 (2003).
40. Tiemersma, D.W. et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg. Infect. Dis. 10, 1627-1634 (2004).
41. Blower, S.M. & Chou, T. Modeling the emergence of the ‘hot zones’: Tuberculosis and the amplification dynamics of drug resistance. Nat. Med. 10, 1111-1116 (2004).
42. Drucker, E., Alcabes, P.G. & Marx, P.A. The injection century: Massive unsterile injections and the emergence of human pathogens. Lancet 358, 1989-1992 (2001).
43. Darby, S.C. et al. Mortality before and after HIV infection in the complete UK population of haemophiliacs. Nature377, 79-82 (1995).
44. Pealer, L.N. et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N. Engl. J. Med. 349, 1236-1245 (2003).
45. Iwamoto, M. et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N. Engl. J. Med. 348, 2196-2203 (2003).
46. Butel, J.S. & Lednicky, J.A. Cell and molecular biology of simian virus 40: Implications for human infections and disease. J. Natl. Cancer. Inst. 91, 119-134 (1999).
47. zur Hausen, H. SV40 in human cancers-an endless tale? Int. J. Cancer. 107, 687 (2003).
48. Patience, C., Takeuchi, Y. & Weiss, R.A. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3, 282-286 (1997).
49. Weiss, R.A. Transgenic pigs and virus adaptation. Nature 391, 327-328 (1998).
50. Magre, S. et al. Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galac- tosyl-a(1-3) galactosyl epitope. J. Virol. 78, 5812-5819 (2004).
51. Weiss, R.A. Gulliver’s travels in HIVland. Nature 410, 963-967 (2001).
52. Weiss, R.A. & McLean, A.R. What have we learnt from SARS? Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359, 1137-1140 (2004).
53. Hale, P. et al. Mission now possible for AIDS fund. Nature 412, 271-272 (2001).
54. Perel, P., McGuire, M., Eapen, K. & Ferraro, A. Research on preventing road traffic injuries in developing countries is needed. BMJ328, 895 (2004).
55. Peiris, J.S.M., Guan, Y. & Yuen, K.Y. Severe acute respiratory syndrome. Nat. Med. 10, S88-S97 (2004).
56. Levy, S.B. & Marshall, B. Antimicrobial resistance worldwide: Causes, challenges and responses. Nat. Med. 10, S122-S129 (2004).
57. Bell, D., Roberton, S. & Hunter, P.R. Animal origins of SARS coronavirus: Possible links with the international trade in small carnivores. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359, 1107-1114 (2004).
58. Mahy, B.W.J. Zoonoses and haemorrhagic fever. in Safety of Biological Products Prepared from Mammalian Cell Culture. Dev. Biol. Stand. 93 (eds. Brown, F., Griffiths, E., Horaud, F. & Petricciani, J.C.) 31-36 (Karger, Basel, 1998).
59. Wolfe, N.D. et al. Naturally acquired simian retrovirus infections in central African hunters. Lancet 363, 932-927 (2004).
60. Di Giulio, D.B. & Eckburg, P.B. Human monkeypox: An emerging zoonosis. Lancet Infect. Dis. 4, 15-25 (2004).